Medical Marijuana Benefits
|
| Rank | Company | Sales ($B) |
|---|---|---|
| 1. | Pfizer | $43.4 |
| 2. | GlaxoSmithKline | $36.5 |
| 3. | Novartis | $36.5 |
| 4. | Sanofi-Aventis | $35.6 |
| 5. | AstraZeneca | $32.5 |
| 6. | Hoffmann-La Roche | $30.3 |
| 7. | Johnson & Johnson | $29.4 |
| 8. | Merck | $26.2 |
| 9. | Abbott | $19.5 |
| 10. | Eli Lilly | $19.1 |
Source: Wikipedia
THC May Help Fight Brain Cancer
A research team led by Guillermo Velasco at Compultense University in Madrid, Spain discovered that cannabinoids such as THC had anticancer effects in mice with human brain cancer cells and humans with brain tumors. When mice with the human brain cancer cells received THC, the tumor growth shrank.Two patients with brain tumors enrolled in a clinical trial for treatment of glioblastoma multiforme, a highly aggressive and recurring brain tumor. Biopsies before and after treatment indicated THC treatment increased autophagy activity and the patients did not experience toxic effects from the medical marijuana treatment. Source: Medical News Today
Marijuana Use And Head And Neck Carcinoma
While this study cannot conclusively determine cause and effect, it does support the thesis that cannabinoids are potential potent anticancer drugs.Analysis based on amount and frequency of marijuana use indicated reduced risk of head and neck squamous cell carcinoma (HNSCC). "Our study suggests that moderate marijuana use is associated with reduced risk of HNSCC." Source: Cancer Prevention Research
Lung Cancer And Chronic Obstructive
Pulmonary Disease (COPD)
Researchers of the Harvard study said their mouse and lab study show THC target cannabinoid receptors CB1 which is found in the brain, and CB2 found in the immune system. CB1 and CB2 are naturally produced in the body. Researchers suggest that THC that activate these receptors may be used in a targeted fashion to treat lung cancer. Source: Science Daily
Amyotrophic Lateral Sclerosis (ALS)
An estimated 30,000 Americans are living with ALS, or Lou Gehrig's disease. Of which, more than half of ALS patients die within 2.5 years following the onset of symptoms. Recent preclinical findings indicate cannabinoids can delay ALS progression. Source: NORMLChronic Pain
The referenced study from UC Davis was published in the Journal of Pain found marijuana effective in reducing neuropathic pain. But they pointed out in their conclusion that the efficacy of marijuana benefits may be limited to how it’s administered. Therefore, efforts by pharmaceutical companies to extract marijuana's active ingredients and package them in pill form may be ill-fated. Source: Third AgeClick here to exit Marijuana Benefits and return to
Health Benefits of Medical Marijuana
Click here to exit Marijauna Benefits and return Home